Based on our findings, EGFR and TP53 mutations were detected from most tumors having an increasing trend concomitant with increased invasiveness, resulting in more predominant mutations in IAC ( EGFR : 30.1% vs. 56.4% vs. 71.5%; TP53 : 0.8% vs. 4.2% vs. 36.2%).
← all excerpts
Distinct mutational features across preinvasive and invasive subtypes identified through comprehensive profiling of surgically resected lung adenocarcinoma.
1
—
—